Hyep Ivan

Hyep Ivan is listed in filings as Chief Financial Officer at Bicara Therapeutics Inc. Common Stock. This profile follows SEC Form 4 activity through May 26, 2026, including sale activity. Recent filings connect the profile to Bicara Therapeutics Inc. Common Stock (BCAX). The current snapshot covers public activity from Oct 8, 2025 to May 26, 2026. Reported amounts are shown as $187.9K to $211.6K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.